Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HBCChem is a specialized chemical supplier and contract research organization (CRO) providing high-quality building blocks, intermediates, and screening compounds to the pharmaceutical and biotechnology industries. Founded in 2002, the company offers an extensive catalog of unique scaffolds, including specialized carbohydrates, nucleosides, and amino acid derivatives, designed to support early-stage drug discovery and medicinal chemistry. Beyond its catalog products, HBCChem provides custom synthesis and process development services ranging from milligram to multi-kilogram scales. The company maintains its headquarters in California with additional research and manufacturing operations in China, serving a global client base of pharmaceutical firms and academic research institutions. Their core business focus is the delivery of novel chemical entities that facilitate the expansion of chemical libraries and accelerate hit-to-lead development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HBCChem.